Recently, Qi Carbon Technology released the first nanopore gene sequencer QNome-3841 to be mass-produced in China, as well as supporting chips and reagents, and announced the completion of its production base in Chengdu Tianfu International Bio-City.
Gene sequencer is the core of the entire gene industry chain, and the requirements for industrialization and engineering are extremely high. The successful release and mass production of the product means that the domestic nanoporous gene sequencing technology has entered the marketization process. At the press conference, Dr. Bai Jingwei, co-founder and chief scientist of Qi Carbon Technology, said: "QNome-3841 is the first fully independently developed nanopore gene sequencer to be mass-produced in China, equipped with a proprietary sequencing chip Qcell-384 and a supporting kit. Positioned as a small-throughput sequencer, it is ideal for small laboratories, outdoors and time-sensitive applications. ”
Qi Carbon Technology also announced the official completion of its production base in Chengdu Tianfu International Bio-City. The production base has a total area of about 4,000 square meters, a total of 3 floors, and a total investment of 200 million yuan. The production base plans to put into production products including library building kits, sequencing kits, biochips, nanoporous gene sequencers, etc. After being put into use, 2,000 nanoporous gene sequencers will be produced every year, supporting 1 million test kits and chips.
It is reported that while engaged in the research and development and manufacturing of nanoporous gene sequencers and supporting chips and reagent consumables, Qi Carbon Technology has been adhering to an open and cooperative attitude, providing technical support and product support for middle and downstream users, and accelerating the construction of an ecological platform based on nanoporous gene sequencing technology.
Hillhouse Venture Capital, which has long been concerned about investment in the biotechnology field, believes that due to the high threshold of the upstream industry in the gene industry, international giants have occupied the most important market share for a long time. In the context of vigorous development of primary innovation in China, the future development space in the field of gene sequencing is huge, domestic enterprises are even more promising, Qi Carbon Technology as the first in China, the world's second to create a nanoporous gene sequencer and is about to start mass production of high-tech enterprises, in the technical barriers, efficiency, cost and other aspects have a strong competitiveness, hope that Qi Carbon Technology can lead the development of China's gene sequencing upstream field, to achieve curve overtaking.
![Another national heavy weapon in China is launched! Although the body is small, it has a big future, completely breaking the monopoly of foreign countries[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)